Varlitinib Completed Phase 2 Trials for Metastatic Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02338245Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab